Werba Rubin Papier Wealth Management Increases Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Werba Rubin Papier Wealth Management increased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 44.6% in the 2nd quarter, HoldingsChannel reports. The firm owned 2,842 shares of the financial services provider’s stock after buying an additional 877 shares during the quarter. Werba Rubin Papier Wealth Management’s holdings in iShares Biotechnology ETF were worth $390,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in IBB. Corient Private Wealth LLC lifted its stake in shares of iShares Biotechnology ETF by 1.0% during the fourth quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock worth $11,778,000 after purchasing an additional 841 shares in the last quarter. Mmbg Investment Advisors CO. boosted its holdings in iShares Biotechnology ETF by 0.6% in the 4th quarter. Mmbg Investment Advisors CO. now owns 78,550 shares of the financial services provider’s stock worth $10,671,000 after acquiring an additional 495 shares during the period. Oppenheimer & Co. Inc. grew its position in iShares Biotechnology ETF by 7.6% in the first quarter. Oppenheimer & Co. Inc. now owns 35,747 shares of the financial services provider’s stock valued at $4,905,000 after acquiring an additional 2,532 shares in the last quarter. Chemistry Wealth Management LLC grew its position in iShares Biotechnology ETF by 20.6% in the first quarter. Chemistry Wealth Management LLC now owns 3,560 shares of the financial services provider’s stock valued at $488,000 after acquiring an additional 609 shares in the last quarter. Finally, Future Financial Wealth Managment LLC acquired a new position in shares of iShares Biotechnology ETF during the first quarter worth $27,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

Shares of IBB stock traded down $2.04 on Friday, hitting $142.75. The stock had a trading volume of 1,310,269 shares, compared to its average volume of 1,536,689. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $150.17. The stock’s 50 day moving average is $144.12 and its 200-day moving average is $138.01.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.